Skip to content

The effect of achillea millefolium on HbA1C and peripheral neuropathy in diabetic patients

Investigating the effect of oral supplement of achillea millefolium on HbA1C and peripheral neuropathy in type 2 diabetic patients

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150713023190N13
Enrollment
70
Registered
2022-05-24
Start date
2022-06-05
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified

Interventions

Sponsors

Rafsanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: Having type II diabetes Age over 40 years old Inform consent for participate in the study Getting a score above 7 from the Michigan neuropathy questionnaire History of diabetes for at least five years

Exclusion criteria

Exclusion criteria: Participate in another research project Having other physical illnesses in addition to diabetes Having psychiatric diseases Pregnancy Lactation History of hereditary neuropathies or underlying diseases that cause neuropathy such as chronic uremia Autoimmune diseases (rheumatism, multiple sclerosis, osteoarthritis) Allergy to medicinal plants Wounds or infections on the feet Lower extremity amputation Use of anticoagulant drugs

Design outcomes

Primary

MeasureTime frame
Mean of HBA1C. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: Spectrophotometer device.;Peripheral neuropathy score. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the intervention. Method of measurement: Michigan neuropathy questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTabandeh Sadeghi

Rafsanjan University of Medical Sciences

t.b_sadeghi@yahoo.com+98 34 3425 5900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026